No results for ‘’
Kashyap Tele-Medicines Ltd
₹5.82
(0%)
Mon, 27 Jul 2026, 07:15 pm
Technology Services
Packaged Software
24.5KKashyap Tele-Medicines EV/EBITDA Ratio
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 141.67 | 242.86 | 295.65 | 0 | 3480 | 0 | 0 |
| Price to book ratio | 1.37 | 1.36 | 1.36 | 4.87 | 14.89 | 15.51 | 34.77 |
| Price to sales ratio | 16.35 | 16.16 | 17.50 | 16.60 | 50.76 | 51.70 | 115.83 |
| Price to cash flow ratio | 101.50 | 0 | 121.13 | 0 | 138.72 | 0 | 0 |
| Enterprise value | 3.1Cr | 3.14Cr | 3.11Cr | 3.22Cr | 9.88Cr | 9.84Cr | 22.23Cr |
| Enterprise value to EBITDA ratio | 100.19 | 211.50 | 228.27 | 0 | 2410 | 0 | 0 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 0.56 | 0.46 | -112.89 | 0.46 | -4.58 | -0.05 |
Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio
The Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Kashyap Tele-Medicines Ltd's valuation, profitability, and overall financial performance. Tracking the Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Kashyap Tele-Medicines Ltd (NSE: , BSE: 531960) is currently trading at ₹5.82, with a market capitalization of ₹27.77Cr. As a leading company in the Technology services sector and Packaged software industry, monitoring the Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio Current Value
The current Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio stands at 0.
The Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.
Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 2410
- 2021: 0
- 2020: 228.27
The decline in Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Kashyap Tele-Medicines Ltd.
Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Kashyap Tele-Medicines Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.